HepaTx Corporation
HepaTx Corporation, based in Palo Alto, CA, is focused on developing off-the-shelf cell therapies for liver disease, utilizing advanced regenerative medicine technologies. With over 30 million Americans affected by liver disease and only a fraction able to receive necessary transplants, HepaTx aims to provide innovative treatment alternatives to improve patient outcomes.
The company prides itself on its scalable manufacturing processes and a curated team of experts dedicated to revolutionizing liver care. By fostering collaboration with entrepreneurial pioneers and distinguished investors, HepaTx is committed to educating the public on accessible alternatives to liver transplantation.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.